Filing Details
- Accession Number:
- 0000899243-18-026882
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-17 17:00:56
- Reporting Period:
- 2018-10-15
- Accepted Time:
- 2018-10-17 17:00:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1496671 | Calithera Biosciences Inc. | CALA | Pharmaceutical Preparations (2834) | 272366329 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1670740 | Keith Orford | C/O Calithera Biosciences, Inc. 343 Oyster Point Blvd. #200 South San Francisco CA 94080 | Sr. Vp, Clinical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-10-15 | 313 | $6.05 | 10,314 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on April 25, 2018.
Billionaire Hedge Funds
